Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days
Clinical trial NCT02547805 · COMPLETED
Trial details
- NCT number
- NCT02547805
- Sponsor
- Allena Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-01-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.